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Leptin is a hormone secreted by the adipose tissue that
may be associated in the general population with com-
ponents of the metabolic syndrome (MS). Our objective
was to test the association between dyslipidemia, MS
presence and circulating leptin dysfunction in a cohort
of HIV-infected non-diabetic patients undergoing com-
binant antiretroviral therapy (cART).
We included HIV-infected non-diabetic consecutive
patients undergoing cART, admitted to the National
Institute for Infectious Diseases “Prof. Dr. Matei Balş”,
between 2008-2011. The diagnosis of MS was made
using the International Diabetes and American Heart
Association harmonized criteria from 2009. Circulating
levels of leptin (BioSource EASIA) were measured.
We enrolled 95 patients: 53 (55.8%) males (mean
age=33.1±13.4 years) and 42 (44.2%) females (mean
age=30.5±13.6 years). Most patients (72.5%) had unde-
tectable HIV viral load; median CD4 count was 493.5
(IQR=422)/cmm. The median time from HIV diagnosis
was 60 (IQR=73) months. The median time on cART
was 58.5 (IQR=70) months, 53.8% of patients had
experienced more than one cART regimen.
The prevalence of MS was 17.1%. Elevated blood pres-
sure, elevated waist circumference and abnormal fasting
glucose prevalences were 30.3%, 17.1% and 6.5%,
respectively.
Median serum leptin was 1.89 (IQR=3.57) ng/mL.
Circulating leptin dysfunction was present in almost half
of patients, hypoleptinemia being more frequent (42.%)
than hyperleptinemia (8.5%). Hypoleptinemia was more
frequent in men (62.3%) comparative to women (17.1%),
p=0.000.
The prevalence of MS in patients with hypoleptinemia
was 25.8% vs 10.8% in persons with normal leptin values
(p=0.261). Hypoleptinemia was associated with elevated
waist circumference (p=0.004) and abnormal fasting
glucose (p=0.05) in women. More than half (65.6%) of
men with hypoleptinemia had reduced HDL-cholesterol
levels vs 29.4% in men with normal levels of leptin. As
expected, hyperleptinemia was associated with the
increase of body mass index, both in men (p=0.000) and
women (p=0.05).
In our cohort of young cART multiexperienced HIV
patients leptin dysfunction was not significantly asso-
ciated with MS presence. Leptin was correlated with
several MS components (HDL-dyslipidemia, elevated
circumference, abnormal fasting glucose) with significant
gender differences, that suggests that leptin may play
different roles in the regulation of glucose and lipid
metabolism according to the sex.
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